Q3 2022 Holdings
Filed 2022-11-14 | 39 holdings | $232.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $82.4M | 1,700,000 | 35.4% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $46.5M | 2,000,000 | 20.0% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $29.1M | 1,525,000 | 12.5% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $28.4M | 2,971,352 | 12.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $25.8M | 250,000 | 11.1% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $9.6M | 750,000 | 4.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $5.5M | 510,000 | 2.4% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $4.6M | 460,075 | 2.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $88.8K | 1,300,000 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $61.7K | 4,135,000 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $48.8K | 1,397,680 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $46.8K | 2,797,501 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $38.7K | 350,000 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $36.3K | 5,936,666 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $33.7K | 150,000 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $29.0K | 2,287,321 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $26.9K | 1,500,000 | 0.0% |
| Dice Therapeutics Inc | COM | 23345J104 | $22.0K | 1,085,251 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $20.5K | 1,000,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $18.1K | 500,000 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $16.4K | 350,000 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $15.8K | 1,950,000 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $13.6K | 400,000 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $11.1K | 850,000 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $10.3K | 3,743,875 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $10.0K | 950,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $8.4K | 800,000 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $8.2K | 950,000 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $4.7K | 2,000,000 | 0.0% |
| Tricida Inc(1T7)Put | COM | 89610F101 | $2.5K | 240,200 | 0.0% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $1.9K | 205,595 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $1.6K | 399,801 | 0.0% |
| Instil BIO Inc | COM | 45783C101 | $1.6K | 331,872 | 0.0% |
| Spruce Biosciences Inc | COM | 85209E109 | $1.4K | 1,000,000 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $1.1K | 127,316 | 0.0% |
| Lianbio | SPONSORED ADS | 53000N108 | $616 | 307,908 | 0.0% |
| Talaris Therapeutics Inc | COM | 87410C104 | $521 | 197,913 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $434 | 220,434 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $13 | 66,666 | 0.0% |